Sanghvi Brands Ltd

Sanghvi Brands Ltd. reported the utilization of issue proceeds for the half year and financial year ended March 31, 2026, as reviewed by the Audit Committee. Out of ₹1896.12 Lakhs raised, ₹1713.52 Lakhs has been utilized, with ₹164.18 Lakhs pending utilization. The funds were primarily allocated to business expansion, marketing and sales promotion, strategic investments, general corporate purposes, and issue expenses. The company confirms no deviation in the use of funds raised, and the utilized proceeds align with the prospectus objectives.

Sanghvi Brands Ltd. announced the appointment of Mr. Rohit Prakash Bafana (DIN: 00590469) as an Additional Non-Executive Independent Director. The decision was made during a Board of Directors meeting on May 21, 2026, and is subject to shareholder approval. Mr. Bafana's appointment is in compliance with the Companies Act, 2013, SEBI Circulars, and Listing Regulations. He is currently the MD of United Chem Energy Trading Pvt. Ltd. and a co-founder of FamilyCare Clinic Private Limited and Indian Naturals.

Sanghvi Brands Ltd. announced the approval of its standalone and consolidated financial results for the half and financial year ended March 31, 2026. The decision was made during a Board of Directors meeting held on May 21, 2026. The board also approved the appointment of Mr. Rohit Prakash Bafana as an Additional Non-Executive Independent Director, subject to shareholder approval. The financial statements and related disclosures are available on the company's website.

Sanghvi Brands Ltd. announced the Board of Directors approved the annual audited standalone and consolidated financial statements for the financial year ended March 31, 2026. The meeting, held on May 21, 2026, also saw the appointment of Mr. Rohit Prakash Bafana as an Additional Non-Executive Independent Director, subject to shareholder approval.

Sanghvi Brands Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the annual audited financial statements (standalone and consolidated) for the financial year ended March 31, 2026. The board will also consider the appointment of Mr. Rohit Prakash Bafana as an Additional Non-Executive Independent Director, subject to shareholder approval. The trading window for dealing in the company's securities has been closed from April 1, 2026, until 48 hours after the declaration of the audited financial results.

In accordance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares & Takeovers) Regulation, 2011, Disha Narendra Sanghvi, a promoter of Sanghvi Brands Ltd, has disclosed that she did not make any encumbrance on the shares of the company, either directly or indirectly, during the financial year ending March 31, 2026. This annual disclosure confirms her holding of 69011 equity shares in Sanghvi Brands Ltd as of the mentioned date.

Sanghvi Brands Ltd, in accordance with Regulation 31(4) of Securities and Exchange Board of India (Substantial Acquisition of Shares& Takeovers) Regulation, 2011, has disclosed the annual encumbrance of shares by promoter Darpan Narendra Sanghvi. The disclosure, made for the financial year ending March 31, 2026, confirms that Mr. Sanghvi did not make any encumbrance on the shares of Sanghvi Brands Limited, either directly or indirectly, during the Financial Year 2025-2026. The declaration was made by Darpan Narendra Sanghvi, who holds 5499945 Equity Shares of Sanghvi Brands Limited as on March 31, 2026.

In accordance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares & Takeovers) Regulation, 2011, Kamini Narendra Sanghvi, a promoter of Sanghvi Brands Ltd, has disclosed that she did not make any encumbrance on the shares of Sanghvi Brands Limited, directly or indirectly, during the Financial Year 2025-2026. The disclosure was made in an annual disclosure submitted for the financial year ended on March 31, 2026.

Sanghvi Brands Ltd has informed the Exchange(s) of all necessary events and informations that have a bearing on the operation/performance of the company, including all price sensitive informations as required under Regulation 30 of the SEBI (Lisiting Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that there is no impending announcement or withheld disclosure of any material information/event that may have a bearing on the price/volume behavior in the scrip of the company. The increase or spurt in the volume in the companies scrip is purely due to market conditions and is, apparently, market driven, on which the company has no control.

Sanghvi Brands Ltd has announced the closure of its trading window for its Designated Persons and their immediate relatives. The closure is in compliance with the Regulation 9 read with Clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from April 01, 2026, till the expiry of 48 hours after the Audited Financial Results (Standalone and Consolidated) of the Company for the financial year ended on March 31, 2026 become generally available information. This move is to ensure that all Designated Persons and their immediate relatives do not enter into any transactions involving dealing/trading in securities of the Company during the aforesaid period of closure of Trading Window.